Breaking News

Oxford/AstraZeneca vaccine: rare blood clot syndrome has high mortality rate

Researchers found that clots occurring after first dose of Oxford jab affected otherwise young and healthy people * Coronavirus – latest updates * See all our coronavirus coverage Although extremely rare, a blood clot syndrome after the first dose of the Oxford/AstraZeneca vaccine carries a high risk of death and can occur in otherwise young and healthy people, UK researchers have found. In those aged under 50, blood clots occur in around one in 50,000 people who have received the vaccine, data suggests. Continue reading...

No comments